KRIT1/Cerebral Cavernous Malformation 1 Protein Localizes to Vascular Endothelium, Astrocytes, and Pyramidal Cells of the Adult Human Cerebral Cortex

Neurosurgery

Volumn 54, Issue 4, 2004, Pages 943-949

  Guzeloglu Kayisli, Ozlem ^a,b   Amankulor, Nduka M ^a   Voorhees, Jennifer ^a   Luleci, Guven ^b   Lifton, Richard P ^a   Gunel, Murat ^a   Hodge Jr , Charles J ^c   Takagi, Yasushi ^c   Hashimoto, Nobuo ^c   Connolly Jr , E Sander ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AKDENIZ UNIVERSITY   (Turkey)

^c TMP 4 ^*

Author keywords

Astrocytes; Blood brain barrier; Cerebral cavernous malformation; Endothelium; KRIT1

Indexed keywords

INTEGRIN; INTEGRIN CYTOPLASMIC DOMAIN ASSOCIATED PROTEIN 1ALPHA; MICROTUBULE PROTEIN; PROTEIN KRIT1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTERIOLE; ARTICLE; ASTROCYTE; AUTOSOMAL DOMINANT DISORDER; BLOOD BRAIN BARRIER; BRAIN CORTEX; CAPILLARY; CENTRAL NERVOUS SYSTEM DISEASE; CEREBRAL CAVERNOUS MALFORMATION; CONGENITAL BLOOD VESSEL MALFORMATION; GENE MUTATION; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PYRAMIDAL NERVE CELL; SPLEEN; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

EID: 12144290066     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000114512.59624.A5     Document Type: Article

References (31)

1. Bouvard D, Vignoud L, Dupe-Manet S, Abed N, Fournier HN, Vincent-Monegat C, Retta SF, Fassler R, Block MR: Disruption of focal adhesions by integrin cytoplasmic domain-associated protein-1α. J Biol Chem 278:6567-6574, 2003.
2. Cave-Riant F, Denier C, Labauge P, Cecillon M, Maciazek J, Joutel A, Laberge-Le Couteulx S, Tournier-Lasserve E: Spectrum and expression analysis of KRIT1 mutations in 121 consecutive and unrelated patients with cerebral cavernous malformations. Eur J Hum Genet 10:733-740, 2002.
3. Chang DD, Wong C, Smith H, Liu J: ICAP-1, a novel β1 integrin cytoplasmic domain-associated protein, binds to a conserved and functionally important NPXY sequence motif of β1 integrin. J Cell Biol 138:1149-1157, 1997.
4. Chen DH, Lipe HP, Qin Z, Bird TD: Cerebral cavernous malformation: Novel mutation in a Chinese family and evidence for heterogeneity. J Neurol Sci 196:91-96, 2002.
5. Clatterbuck RE, Cohen B, Gailloud P, Murphy K, Rigamonti D: Vertebral hemangiomas associated with familial cerebral cavernous malformation: Segmental disease expression-Case report. J Neurosurg 97:227-230, 2002.
6. Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D: Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry 71:188-192, 2001.
7. Couteulx SL, Brezin AP, Fontaine B, Tournier-Lasserve E, Labauge P: A novel KRIT1/CCM1 truncating mutation in a patient with cerebral and retinal cavernous angiomas. Arch Ophthalmol 120:217-218, 2002.
8. Craig HD, Gunel M, Cepeda O, Johnson EW, Ptacek L, Steinberg GK, Ogilvy CS, Berg MJ, Crawford SC, Scott RM, Steichen-Gersdorf E, Sabroe R, Kennedy CTC, Mettler G, Beis MJ, Fryer A, Awad IA, Lifton RP: Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet 7:1851-1858, 1998.
9. Davenport WJ, Siegel AM, Dichgans J, Drigo P, Mammi I, Pereda P, Wood NW, Rouleau GA: CCM1 gene mutations in families segregating cerebral cavernous malformations. Neurology 56:540-543, 2001.
10. Denier C, Gasc JM, Chapon F, Domenga V, Lescoat C, Joutel A, Toumier-Lasserve E: Krit1/cerebral cavernous malformation 1 mRNA is preferentially expressed in neurons and epithelial cells in embryo and adult. Mech Dev 117:363-367, 2002.
11. Eerola I, Plate KH, Spiegel R, Boon LM, Mulliken JB, Vikkula M: KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation. Hum Mol Genet 9:1351-1355, 2000.
12. Gunel M, Laurans MS, Shin D, DiLuna ML, Voorhees J, Choate K, Nelson-Williams C, Lifton RP: KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein. Proc Natl Acad Sci U S A 99:10677-10682, 2002.
13. Kehrer-Sawatzki H, Wilda M, Braun VM, Richter HP, Hameister H: Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1). Acta Neuropathol (Berl) 104:231-240, 2002.
14. Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y, Noda M: A ras-related gene with transformation suppressor activity. Cell 56:77-84, 1989.
15. Knox AL, Brown NH: Rap1 GTPase regulation of adherens junction positioning and cell adhesion. Science 295:1285-1288, 2002.
16. Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, Cecillon M, Marechal E, Joutel A, Bach JF, Toumier-Lasserve E: Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23:189-193, 1999.
17. Lucas M, Solano F, Zayas M.D., Garcia-Moreno JM, Gamero MA, Costa AF, Izquierdo G: Spanish families with cerebral cavernous angioma do not bear 742C→T Hispanic American mutation of the KRIT1 gene. Ann Neurol 47:836, 2000 (letter).
18. Marchuk DA, Srinivasan S, Squire TL, Zawistowski JS: Vascular morphogenesis: Tales of two syndromes. Hum Mol Genet 12:R97-R112, 2003.
19. McCarty JH, Monahan-Earley RA, Brown LF, Keller M, Gerhardt H, Rubin K, Shani M, Dvorak HF, Wolburg H, Bader BL, Dvorak AM, Hynes RO: Defective associations between blood vessels and brain parenchyma lead to cerebral hemorrhage in mice lacking av integrins. Mol Cell Biol 22:7667-7677, 2002.
20. Roda A, Pasini P, Guardigli M, Baraldini M, Musiani M, Mirasoli M: Bio- and chemiluminescence in bioanalysis. Fresenius J Anal Chem 366:752-759, 2000.
21. Russell DS, Rubenstein LJ: Pathology of Tumors of the Nervous System. Baltimore, Williams & Wilkins, 1989, pp 730-736.
22. Sahoo T, Johnson EW, Thomas JW, Kuehl PM, Jones TL, Dokken CG, Touchman JW, Gallione CJ, Lee-Lin SQ, Kosofsky B, Kurth JH, Louis DN, Mettler G, Morrison L, Gil-Nagel A, Rich SS, Zabramski JM, Boguski MS, Green ED, Marchuk DA: Mutations in the gene encoding KRIT1, a Krev-1/rapla binding protein, cause cerebral cavernous malformafions (CCM1). Hum Mol Genet 8:2325-2333, 1999.
23. Serebriiskii I, Estojak J, Sonoda G, Testa JR, Golemis EA: Association of Krev-1/rapla with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 15:1043-1049, 1997.
24. Verlaan DJ, Davenport WJ, Stefan H, Sure U, Siegel AM, Rouleau GA: Cerebral cavernous malformations: Mutations in Krit1. Neurology 58:853-857, 2002.
25. Verlaan DJ, Siegel AM, Rouleau GA: Kritl missense mutations lead to splicing errors in cerebral cavernous malformation. Am J Hum Genet 70:1564-1567, 2002.
26. Wolburg H, Lippoldt A: Tight junctions of the blood-brain barrier: Development, composition and regulation. Vasc Pharmacol 38:323-337, 2002.
27. Wong JH, Awad IA, Kim JH: Ultrastructural pathological features of cerebrovascular malformations: A preliminary report. Neurosurgery 46:1454-1459, 2000.
28. Zawistowski JS, Serebriiskii IG, Lee MF, Golemis EA, Marchuk DA: KRIT1 association with the integrin-binding protein ICAP-1: A new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum Mol Genet 11:389-396, 2002.
29. Zhang J, Clatterbuck RE, Rigamonti D, Chang DD, Dietz HC: Interacfion between krit1 and icap1α infers perturbation of integrin β1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 10:2953-2960, 2001.
30. Zhang J, Clatterbuck RE, Rigamonti D, Dietz HC: Mutations in KRIT1 in familial cerebral cavernous malformations. Neurosurgery 46:1272-1279, 2000.
31. Zhu J, Motejlek K, Wang D, Zang K, Schmidt A, Reichardt LF: β8 integrins are required for vascular morphogenesis in mouse embryos. Development 129:2891-2903, 2002.